177 related articles for article (PubMed ID: 9816030)
21. Polyamine depletion by ODC-AdoMetDC antisense adenovirus impairs human colorectal cancer growth and invasion in vitro and in vivo.
Zhang B; Liu XX; Zhang Y; Jiang CY; Hu HY; Gong L; Liu M; Teng QS
J Gene Med; 2006 Aug; 8(8):980-9. PubMed ID: 16783835
[TBL] [Abstract][Full Text] [Related]
22. Loss of heterozygosity at 18q21 is indicative of recurrence and therefore poor prognosis in a subset of colorectal cancers.
Jernvall P; Mäkinen MJ; Karttunen TJ; Mäkelä J; Vihko P
Br J Cancer; 1999 Feb; 79(5-6):903-8. PubMed ID: 10070888
[TBL] [Abstract][Full Text] [Related]
23. Polyamines, diamine oxidase, and ornithine decarboxylase activity in colorectal cancer and in normal surrounding mucosa.
Linsalata M; Russo F; Cavallini A; Berloco P; Di Leo A
Dis Colon Rectum; 1993 Jul; 36(7):662-7. PubMed ID: 8348850
[TBL] [Abstract][Full Text] [Related]
24. Predictive role of thymidylate synthase, dihydropyrimidine dehydrogenase and thymidine phosphorylase expression in colorectal cancer patients receiving adjuvant 5-fluorouracil.
Ciaparrone M; Quirino M; Schinzari G; Zannoni G; Corsi DC; Vecchio FM; Cassano A; La Torre G; Barone C
Oncology; 2006; 70(5):366-77. PubMed ID: 17179731
[TBL] [Abstract][Full Text] [Related]
25. Prognostic value of ornithine decarboxylase and polyamines in human breast cancer: correlation with clinicopathologic parameters.
Cañizares F; Salinas J; de las Heras M; Diaz J; Tovar I; Martinez P; Peñafiel R
Clin Cancer Res; 1999 Aug; 5(8):2035-41. PubMed ID: 10473083
[TBL] [Abstract][Full Text] [Related]
26. [Clinical significance of human telomerase reverse transcriptase in patients with colon cancer].
Li LR; Wan DS; Pan ZZ; Hardingham J; Rieger N; Hewett P; Zhou ZW; Chen G
Ai Zheng; 2004 Nov; 23(11 Suppl):1502-7. PubMed ID: 15566667
[TBL] [Abstract][Full Text] [Related]
27. Colorectal ornithine decarboxylase activity in human mucosa and tumors: elevation of enzymatic activity in distal mucosa.
Nishioka K; Grossie VB; Chang TH; Ajani JA; Ota DM
J Surg Oncol; 1991 Jun; 47(2):117-20. PubMed ID: 2062082
[TBL] [Abstract][Full Text] [Related]
28. [A study of ornithine decarboxylase activity in tumor tissue and rectal mucosa in patients with colorectal cancer or adenoma].
Murakami S; Haruma K; Sumii K; Tari A; Yoshihara M; Inoue K; Kimura M; Matsubara H; Teshima H; Tokumo K
Nihon Shokakibyo Gakkai Zasshi; 1989 Jun; 86(6):1260-5. PubMed ID: 2795955
[TBL] [Abstract][Full Text] [Related]
29. No difference in stem cell somatic mutation between the background mucosa of right- and left-sided sporadic colorectal carcinomas.
Campbell F; Appleton MA; Shields CJ; Williams GT
J Pathol; 1998 Sep; 186(1):31-5. PubMed ID: 9875137
[TBL] [Abstract][Full Text] [Related]
30. Genetic alterations of the ornithine decarboxylase gene in human colorectal cancers.
Matsubara N; Yoshitaka T; Hanafusa H; Tanaka N; Shimizu K
J Exp Clin Cancer Res; 2002 Jun; 21(2):191-5. PubMed ID: 12148577
[TBL] [Abstract][Full Text] [Related]
31. Telomere length and human telomerase reverse transcriptase expression as markers for progression and prognosis of colorectal carcinoma.
Gertler R; Rosenberg R; Stricker D; Friederichs J; Hoos A; Werner M; Ulm K; Holzmann B; Nekarda H; Siewert JR
J Clin Oncol; 2004 May; 22(10):1807-14. PubMed ID: 15143073
[TBL] [Abstract][Full Text] [Related]
32. Treatment of colorectal neoplasia: clinicopathologic staging, management, and follow-up findings.
Marks CG
Surg Annu; 1993; 25 Pt 1():127-40. PubMed ID: 7677930
[No Abstract] [Full Text] [Related]
33. Elevated expression of the ornithine decarboxylase gene in human esophageal cancer.
Yoshida M; Hayashi H; Taira M; Isono K
Cancer Res; 1992 Dec; 52(23):6671-5. PubMed ID: 1423312
[TBL] [Abstract][Full Text] [Related]
34. Matrilysin (MMP-7) as a significant determinant of malignant potential of early invasive colorectal carcinomas.
Masaki T; Matsuoka H; Sugiyama M; Abe N; Goto A; Sakamoto A; Atomi Y
Br J Cancer; 2001 May; 84(10):1317-21. PubMed ID: 11355941
[TBL] [Abstract][Full Text] [Related]
35. Activation of human squamous cell carcinoma ornithine decarboxylase activity by guanosine triphosphate.
Hietala O; Dzubow L; Dlugosz AA; Pyle JA; Jenney F; Gilmour SK; O'Brien TG
Cancer Res; 1988 Mar; 48(5):1252-7. PubMed ID: 3342404
[TBL] [Abstract][Full Text] [Related]
36. Correlation of Skp2 with carcinogenesis, invasion, metastasis, and prognosis in colorectal tumors.
Li JQ; Wu F; Masaki T; Kubo A; Fujita J; Dixon DA; Beauchamp RD; Ishida T; Kuriyama S; Imaida K
Int J Oncol; 2004 Jul; 25(1):87-95. PubMed ID: 15201993
[TBL] [Abstract][Full Text] [Related]
37. A randomized, placebo-controlled trial of low-dose alpha-difluoromethylornithine in individuals at risk for colorectal cancer.
Love RR; Jacoby R; Newton MA; Tutsch KD; Simon K; Pomplun M; Verma AK
Cancer Epidemiol Biomarkers Prev; 1998 Nov; 7(11):989-92. PubMed ID: 9829706
[TBL] [Abstract][Full Text] [Related]
38. Increased expression of ornithine decarboxylase messenger RNA in human esophageal carcinoma.
Mafune K; Tanaka Y; Mimori K; Mori M; Takubo K; Makuuchi M
Clin Cancer Res; 1999 Dec; 5(12):4073-8. PubMed ID: 10632342
[TBL] [Abstract][Full Text] [Related]
39. Xanthine oxidoreductase - clinical significance in colorectal cancer and in vitro expression of the protein in human colon cancer cells.
Linder N; Martelin E; Lundin M; Louhimo J; Nordling S; Haglund C; Lundin J
Eur J Cancer; 2009 Mar; 45(4):648-55. PubMed ID: 19112016
[TBL] [Abstract][Full Text] [Related]
40. Fatty acid synthase hyperactivation in human colorectal cancer: relationship with tumor side and sex.
Notarnicola M; Altomare DF; Calvani M; Orlando A; Bifulco M; D'Attoma B; Caruso MG
Oncology; 2006; 71(5-6):327-32. PubMed ID: 17687193
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
